RIGEL PHARMACEUTICALS, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C07D HETEROCYCLIC COMPOUNDS 19738
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 17795
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 52154
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 4085
 
  
 
C07F ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM 3139
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 31136
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 2273
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 1633
 
  
 
C07K PEPTIDES 11125
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 1089

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0064,646 METHOD AND DEVICE FOR ADMINISTERING XINAFOATE SALT OF N4-(2,2-DIFLUORO-4H-BENZO[1,4]OXAZIN-3-ONE)-6-YL]-5-FLUORO-N2-[3-(METHYLAMINOCARBONYLMETHYLENEOXY)PHENYL]2,4-PYRIMIDINEDIAMINENov 09, 17Mar 08, 18[A61K, A61M]
2017/0369,476 2,4-DIAMINO-PYRIMIDINE COMPOUNDS AND METHOD FOR MAKING AND USING THE COMPOUNDSJun 26, 17Dec 28, 17[C07D]
2017/0360,786 Protein Kinase C Inhibitors and Uses ThereofDec 30, 16Dec 21, 17[A61K, C07D]
2017/0291,909 Prodrugs of 2,4-Pyrimidinediamine Compounds and Their UsesNov 23, 16Oct 12, 17[C07F, C07D]
2017/0158,683 COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAYFeb 22, 17Jun 08, 17[C07F, C07D, C07B]
2017/0121,291 COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAYOct 11, 16May 04, 17[C07D]
2017/0042,891 AXL INHIBITORS FOR USE IN COMBINATION THERAPY FOR PREVENTING, TREATING OR MANAGING METASTATIC CANCERMar 22, 16Feb 16, 17[A61K]
2014/0206,708 COMPOSITION FOR OPHTHALMIC ADMINISTRATIONJan 24, 14Jul 24, 14[A61K]
2013/0269,046 Model for Muscle AtrophySep 26, 11Oct 10, 13[A01K, G01N]
2011/0144,330 2,4-Pyrimidinediamine Compounds and their UsesJan 21, 11Jun 16, 11[C07D]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9920041 Compositions and methods for inhibition of the JAK pathwayFeb 22, 17Mar 20, 18[C07F, C07D, C07B]
9913842 2,4-pyrimidinediamine compounds and their usesJul 08, 16Mar 13, 18[A61K]
9913843 Protein kinase C inhibitors and uses thereofMay 14, 15Mar 13, 18[A61K, C07D]
9890144 Compounds and method for treating autoimmune diseasesJun 25, 15Feb 13, 18[A61K, C07F, C07D]
9884868 TGF-beta inhibitorsFeb 26, 16Feb 06, 18[C07D]
9878992 GDF-8 inhibitorsJul 13, 17Jan 30, 18[C07F, C07D]
9845307 Nrf2 activating compounds and uses thereofFeb 02, 17Dec 19, 17[C07D]
9845311 Nrf2 activating compounds and uses thereofFeb 01, 17Dec 19, 17[C07D]
9845512 Screening assay employing Dex and GDF8Jan 05, 11Dec 19, 17[A61K, C12Q, C12N]
9834568 Kinase inhibitors and their usesJun 30, 15Dec 05, 17[A61K, C07D, A61P]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2015/0087,673 METHODS FOR USING AND BIOMARKERS FOR AMPK-ACTIVATING COMPOUNDSAbandonedSep 26, 14Mar 26, 15[A61K, C07D, G01N]
2014/0363,443 TRICYCLIC CARBAMATE JAK INHIBITORSAbandonedAug 22, 14Dec 11, 14[A61K, C07D]
2014/0213,555 COMPOUNDS AND METHOD FOR TREATING AUTOIMMUNE DISEASESAbandonedJan 24, 14Jul 31, 14[C07F, C07D]
2013/0310,278 Multiparameter FACS Assays to Detect Alterations in Cellular Parameters and to Screen Small Molecule LibrariesAbandonedNov 07, 12Nov 21, 13[G01N]
2013/0310,340 METHOD OF TREATING MUSCULAR DEGRADATIONAbandonedMay 15, 13Nov 21, 13[A61K]
2013/0281,446 XINAFOATE SALT OF N4-(2,2-DIFLUORO-4H-BENZO[1,4]OXAZIN-3-ONE)-6-YL]-5-FLUORO-N2-[3-(METHYLAMINOCARBONYLMETHYLENEOXY)PHENYL]2,4-PYRIMIDINEDIAMINEAbandonedJun 18, 13Oct 24, 13[A61K]
2013/0274,277 TREATMENT FOR DISCOID LUPUSAbandonedMay 30, 13Oct 17, 13[A61K, C07D]
2013/0102,596 METHOD AND DEVICE FOR ADMINISTERING XINAFOATE SALT OF N4-(2,2-DIFLUORO-4H-BENZO [1,4]OXAZIN-3-ONE)-6-YL]-5-FLUORO-N2-[3- (METHYLAMINOCARBONYLMETHYLENEOXY) PHENYL]2,4-PYRIMIDINEDIAMINEAbandonedOct 19, 12Apr 25, 13[A61K, A61P, A61M, B65B]
2012/0253,039 Methods of Treating or Preventing Autoimmune Diseases with 2,4-Pyrimidinediamine CompoundsAbandonedApr 09, 12Oct 04, 12[C07D]
2011/0130,415 PROTEIN KINASE C INHIBITORS AND USES THEREOFAbandonedDec 01, 10Jun 02, 11[A61K, C12Q, C07D, C12N, A61P]
2011/0104,662 Methods of Detecting Inhibitors of VIF-Mediated APOBEC3G Degradation and HIVAbandonedNov 17, 10May 05, 11[C12Q]
2011/0028,503 COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAYAbandonedJul 28, 10Feb 03, 11[A61K, C07D, A61P]
2011/0015,155 Deuterated 2, 4-Pyrimidinediamine Compounds and Prodrugs Thereof and Their UsesAbandonedJul 16, 10Jan 20, 11[A61K, C07F, C07D, A61P]
7714137 Pyridyl substituted heterocycles useful for treating or preventing HCV infectionExpiredDec 20, 07May 11, 10[C07D]
2010/0041,678 COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY DISORDERSAbandonedAug 13, 09Feb 18, 10[A61K]
2009/0306,028 COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY DISORDERSAbandonedJun 12, 09Dec 10, 09[A61K, A61P]
7598050 Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a chloride intracellular channel 1 proteinExpiredDec 08, 06Oct 06, 09[A61K, G01N, C07K]
2009/0176,202 Methods of Detecting Inhibitors of VIF-Mediated APOBEC3G Degradation and HIVAbandonedMar 24, 08Jul 09, 09[C12Q, C12N]
7521192 EDG: modulators of lymphocyte activation and migrationExpiredOct 03, 01Apr 21, 09[G01N]
2009/0093,494 4-Pyrimidineamine Compounds And Uses As Anti-Proliferative AgentsAbandonedDec 12, 08Apr 09, 09[A61K, C07D, A61P]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.